Savara Inc (SVRA)

1.28 -0.01  -0.78% NASDAQ Jul 28, 10:08 USD
View Full Chart
Price Chart
View All SVRA News

News

View All Events

Events

Date Type Description
08/06/2021 Earnings Results Q2 2021 Earnings Results
08/06/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
06/10/2021 16:00 EST AGM 2021 Annual General Meeting
05/13/2021 Earnings Results Q1 2021 Earnings Results
11/05/2020 Earnings Results Q3 2020 Earnings Results
08/06/2020 16:30 EST Earnings Calls Q2 2020 Earnings Call
08/06/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases. It offers products such as AeroVanc, for the treatment of persistent methicillin-resistant staphylococcus aureus and lung infection in cystic fibrosis patients; Molgradex, for the treatment of autoimmune pulmonary alveolar proteinosis and Aironite, an inhaled nebulized sodium nitrite solution to treat heart failure with preserved ejection fraction. All the business activity of the firm functions through the region of the United States.
  • URL: http://www.savarapharma.com
  • Investor Relations URL: https://savarapharma.com/investors/events-presentations/
  • HQ State/Province: Texas
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 13, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.